1 |
JADAUN G P, DAS R, UPADHYAY P,et al. Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from India[J]. Int J Antimicrob Agents, 2009,33(5):483-486.
|
2 |
World Health Organization. Global Tuberculosis Report 2021[R/OL]. (2021-10-14). .
|
3 |
张春雷,丁豪帅,康亚芬,等. 结核杆菌特异性细胞免疫与结核抗体辅助诊断男性生殖系统结核的价值[J]. 实用医学杂志,2021,37(20):2670-2674.
|
4 |
SUN Q, XIAO T Y, LIU H C, et al. Mutations within embCAB Are Associated with Variable Level of Ethambutol Resistance in Mycobacterium tuberculosis Isolates from China[J]. Antimicrob Agents Chemother, 2017,62(1):e01279-17.
|
5 |
RAMASWAMY S V, AMIN A G, GÖKSEL S, et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis[J]. Antimicrob Agents Chemother, 2000,44(2):326-336.
|
6 |
赵雁林. 结核病实验室检验规程[M]. 北京:人民卫生出版社,2015:39-42,67-70.
|
7 |
AMINI S, HOFFNER S, ALLAHYAR TORKAMAN M R, et al. Direct drug susceptibility testing of Mycobacterium tuberculosis using the proportional method: A multicenter study[J]. J Glob Antimicrob Resist, 2019,17:242-244.
|
8 |
DE ALMEIDA I N, SILVA CARVALHO W DA, ROSSETTI M L,et al.Evaluation of six different DNA extraction methods for detection of Mycobacterium tuberculosis by means of PCR-IS6110: preliminary study[J]. BMC Res Notes, 2013,6:561.
|
9 |
WILSON T M. Clinical experience with ethambutol[J]. Antibiot Chemother,1970,(16):222-229.
|
10 |
AHMAD S, MOKADDAS E, AL-MUTAIRI N, et al. Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country[J]. PLoS One, 2016,11(4):e0153563.
|
11 |
BAKULA Z, NAPIORKOWSKA A, BIELECKI J, et al. Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland[J]. Biomed Res Int, 2013,(2013):167954.
|
12 |
JIA H, XU Y, SUN Z.Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China[J]. Antibiotics (Basel), 2021,10(11):1367.
|
13 |
PLINKE C, RUSCH GERDES S, NIEMANN S. Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates[J]. Antimicrob Agents Chemother, 2006,50(5):1900-1902.
|
14 |
MOKROUSOV I, OTTEN T, VYSHNEVSKIY B, et al. Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from Northwestern Russia: implications for genotypic resistance testing[J]. J Clin Microbiol,2002,40(10):3810-3813.
|
15 |
SHI D, LI L, ZHAO Y, et al. Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China[J]. J Antimicrob Chemother, 2011,66(10):2240-2247.
|
16 |
SAFI H, LINGARAJU S, AMIN A, et al. Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-β-D-arabinose biosynthetic and utilization pathway genes[J]. Nat Genet, 2013,45(10):1190-1197.
|
17 |
KHOSRAVI A D, SIROUS M, ABDI M, et al. Characterization of the most common embCAB gene mutations associated with ethambutol resistance in Mycobacterium tuberculosis isolates from Iran[J]. Infect Drug Resist, 2019,12:579-584.
|
18 |
XIANG X, GONG Z, DENG W, et al. Mycobacterial ethambutol responsive genes and implications in antibiotics resistance[J]. J Drug Target, 2021,29(3):284-293.
|
19 |
车洋,杨天池,平国华,等. 宁波地区耐多药结核分枝杆菌乙胺丁醇耐药embB基因突变研究[J]. 中国预防医学杂志, 2018,19(7):505-508.
|
20 |
刘厚明,曾敏,李全,等. embB基因突变与乙胺丁醇药敏表型及耐多药关系的研究[J]. 分子诊断与治疗杂志, 2017,9(1):16-22,32.
|
21 |
XU Y, JIA H, HUANG H, et al. Mutations Found in embCAB, embR, and ubiA Genes of Ethambutol-Sensitive and -Resistant Mycobacterium tuberculosis Clinical Isolates from China[J]. Biomed Res Int, 2015,2015:951706.
|
22 |
SAFI H, FLEISCHMANN R D, PETERSON S N, et al. Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis[J]. Antimicrob Agents Chemother, 2010,54(1):103-108.
|
23 |
吴坤阳,陆烨玮,张明五,等. 浙江省结核分枝杆菌耐药突变特征及其与基因型相关性分析[J]. 中国防痨杂志, 2022,44(11):1126-1134.
|
24 |
孙庆. 结核分枝杆菌乙胺丁醇耐药性与分子特征的相关性研究[D]. 衡阳:南华大学, 2015.
|
25 |
刘翠玉,历素萍,潘宝山,等. 2017-2020年黑龙江省佳木斯市肺结核患者耐药情况分析[J]. 疾病监测, 2021,36(10):1052-1056.
|
26 |
郑扬,赵雁林. 初、复治患者结核分枝杆菌临床分离株对抗结核药物耐药性的分析[J]. 医学研究杂志, 2017,46(4):22-27.
|
27 |
MOHAMMADI B, RAMAZANZADEH R, NOURI B,et al. Frequency of Codon 306 Mutations in embB Gene of Mycobacterium tuberculosis Resistant to Ethambutol: A Systematic Review and Meta-Analysis[J]. Int J Prev Med, 2020,11:112.
|
28 |
徐东芳,刘海灿,赵秀芹,等. 391株结核分枝杆菌基因分型研究和耐药性分析[J]. 中国卫生检验杂志, 2016,26(18):2719-2720,2731.
|